Project description
Novel safety biomarkers for drug development
Testing the safety of drugs is the most important aspect in the drug development pipeline. Although various safety biomarkers have been proposed, substantial sample sizes are required for their validation. The EU-funded TransBioLine project will capitalise on existing data, resources and international collaborations to establish robust biomarkers for use in drug development. Researchers will also develop and validate assays for new safety biomarkers and implement circulating miRNAs as tissue- and mechanism-specific diagnostic tools. Ultimately, the aim is to obtain approval of safety biomarkers as qualified drug development tools by key regulatory authorities such as the EMA and FDA.
Programme(s)
Funding Scheme
IMI2-RIA - Research and Innovation actionCoordinator
8006 Zurich
Switzerland
See on map
Participants (28)
29016 Malaga
See on map
4354 Esch Sur Alzette
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
101 Reykjavik
See on map
80539 Muenchen
See on map
NG7 2RD Nottingham
See on map
37008 Salamanca
See on map
08041 Barcelona
See on map
1110 Wien
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
72770 Reutlingen
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
01307 Dresden
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
82152 Planegg
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
75000 Paris
See on map
28006 Madrid
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
10117 Berlin
See on map
NE1 7RU Newcastle Upon Tyne
See on map
L69 7ZX Liverpool
See on map
41066 Monchengladbach
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
2311 EZ Leiden
See on map
41071 Sevilla
See on map
CT13 9NJ Sandwich
See on map
08889 Whitehouse Station Nj
See on map
RG21 4FA Basingstoke
See on map
4056 Basel
See on map
4070 Basel
See on map
2340 Beerse
See on map
91380 Chilly Mazarin
See on map
85718 Tucson Az
See on map
3012 Bern
See on map